51655-0913 Ondansetron

Product NDC:

51655-0913

Brand Name:

Ondansetron

Generic Name:

Ondansetron

Dosage Form Name:

TABLET, ORALLY DISINTEGRATING

Administration Route:

Oral

Substances:

Name: ONDANSETRON

Strength: 4.0

Unit: mg/1

Packages:

Code: 51655-0913-20

Description: 20 TABLET, ORALLY DISINTEGRATING in 1 BAG (51655-913-20)

Effective Date: June 3, 2022

Discontinued:

Code: 51655-0913-53

Description: 10 TABLET, ORALLY DISINTEGRATING in 1 BAG (51655-913-53)

Effective Date: Jan. 22, 2021

Discontinued:

SEER*Rx Category:

Ancillary Therapy

Major Class:

Antiemetic

Minor Class:

5HT3 Receptor Antagonist

Orphan Drug Designation:

Status:

In Use

CanMED and the Oncology Toolbox